Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 214440
Company: GLENMARK PHARMS LTD
Company: GLENMARK PHARMS LTD
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
REGADENOSON | REGADENOSON | 0.4MG/5ML(0.08MG/ML) | INJECTABLE;INJECTION | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
01/14/2022 | ORIG-1 | Tentative Approval | STANDARD |
Label is not available on this site. |